ETF Industry Leader Kevin Kelly Launches New Business, Introduces Cutting-Edge Suite of ETFs
January 13 2022 - 9:00AM
Business Wire
Inaugural products focus on emerging and
transformative industries, including gene editing, hospitality and
residential real estate
Kelly ETFs, a new exchange-traded fund (ETF) issuer that seeks
to bring forward-looking and disruptive investment products to
market, officially launches today.
The firm’s first round of innovative ETFs also began trading,
including:
- The Kelly CRISPR & Gene Editing Technology ETF
(Nasdaq: XDNA). XDNA is designed to capitalize on the next
generation of healthcare by investing in companies disrupting the
genomic and life science industries. The fund seeks to track the
Strategic CRISPR & Gene Editing Technology Index, which
measures the performance of developed market companies that
specialize in DNA modification systems and technologies. The
subsectors of this fund include CRISPR & Gene Editing
Technology, Gene Editing Development Solutions and Gene Editing
Sequencing Solutions.
- The Kelly Hotel & Lodging Sector ETF (NYSE Arca:
HOTL). The lodging ecosystem includes many specialized players,
and by seeking to track the Strategic Hotel & Lodging Sector
Index, HOTL offers exposure to companies focused on hotel and
lodging management and operations, lodging platform services,
timeshare properties and real estate throughout the developed
world. The hotel and lodging sector acts as an effective economic
barometer as it uniquely captures both leisure and business
spending across various income levels.
- The Kelly Residential & Apartment Real Estate ETF
(NYSE Arca: RESI). RESI aims to track the Strategic Residential
& Apartment Real Estate Sector Index, which targets the entire
residential and multifamily real estate industry by giving
investors access to companies specializing in single-family
residential homes, apartment buildings, student housing and
manufactured homes.
“At Kelly ETFs, we believe investors deserve access to
strategies handcrafted with a deep and nuanced understanding of the
forces driving the trends and transformations happening every day,”
said Kevin Kelly, Founder and CEO of Kelly ETFs. “We are
particularly excited about the promising innovation occurring in
CRISPR and gene editing technology. Scientific understanding of DNA
is significantly more advanced today than even a few years ago and
we’re thrilled to be in on the ground floor.”
Kevin Kelly is an established ETF expert with nearly two decades
of financial industry experience. He also serves as the CEO of
Kelly Benchmark Indexes, the index provider and sponsor of the SRVR
and INDS ETFs.
“In regard to residential real estate, historically low housing
supply comes at a time when household growth – the primary driver
of housing demand – is strong and accelerating,” noted Krista
Kelly, who will oversee the firm’s operations and distribution.
“Meanwhile, the hotel and lodging sector is seeing favorable market
conditions as business spending is set to increase over the next
several years.”
Kelly Intelligence is the adviser and index provider for these
funds. To learn more about Kelly ETFs and its product suite, please
visit KellyETFs.com.
About Kelly ETFs
Kelly ETFs strives to create disruptive exchange-traded funds
(ETFs) that offer investors the opportunity to capture highly
liquid, pure-play exposure to the best-in-class companies
identified in each emerging theme or sector, regardless of
geographical location. Based in Denver, the team is committed to
building investment products with exposure to the world’s most
transformative companies and industries. For more information,
visit KellyETFs.com.
Residential and Apartment Real Estate Companies Investing
Risk. Real estate is highly sensitive to general and local
economic conditions and developments. The U.S. real estate market
may, in the future, experience and has, in the past, experienced a
decline in value, with certain regions experiencing significant
losses in property values. Many real estate companies, including
REITs, utilize leverage (and some may be highly leveraged), which
increases investment risk and the risk normally associated with
debt financing, and could potentially increase the Fund’s
volatility and losses.
Hotel and Lodging Industry Risk Companies in the hotels,
resorts sub-industry may be affected by unique supply and demand
factors that do not apply to other sub-industries. Weak economic
conditions in some parts of the world, changes in oil prices and
currency values, political instability in some areas, and the
uncertainty over how long any of these conditions could continue
may have a negative impact on the lodging industry.
DNA Modification Technology Company Risk. DNA
modification technology companies face intense competition, and
products and services with a potentially short product life. These
companies will generally require large amounts of capital
expenditures on research and development, with no guarantee that
the product or service would be successful. They may be heavily
dependent on intellectual property rights. The laws related to
these rights can vary and there is no guarantee that a company will
be able to successfully protect their intellectual property rights.
These companies, like other health care companies, are subject to
various government and regulatory oversight that could hamper or
impede their operations.
Before investing carefully consider a fund’s investment
objective, risks, charges, and expenses contained in the prospectus
available at KellyETFs.com. Read carefully before
investing.
Distributor: Foreside Fund Services, LLC.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220113005174/en/
Media contact: Gregory FCA for Kelly ETFs Kathleen
Elicker, 484-889-6597 KellyETFs@gregoryfca.com
Strategic Trust Kelly CR... (NASDAQ:XDNA)
Historical Stock Chart
From Jun 2024 to Jul 2024
Strategic Trust Kelly CR... (NASDAQ:XDNA)
Historical Stock Chart
From Jul 2023 to Jul 2024